{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.83 vs. cons $0.82",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Total Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.94B vs. cons $1.956B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EBITDA Margin (Company-wide)",
      "prediction": "MISS",
      "answer": "pred ~26.0% vs. cons ~26.3%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 Total Revenue Growth Guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~3.5% vs. cons ~3.5% (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 Adjusted EBITDA Guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$2.16B vs. cons ~$2.16B (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY26 Adjusted EPS Guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$3.51 vs. cons ~$3.53 (FY26)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": -2.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -4.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "IR has a strong track record (Q2'25, Q1'26) of headline EPS/revenue beats being sold off because the ITS margin-bridge and 2H organic acceleration story is fragile; any Q2 softness in ITS margin or orders forces analysts to trim FY26/FY27 out-period estimates (the back-half ramp needed to hit the $3.45-3.57 EPS guide becomes harder), producing continued drift lower over the following days rather than a snap-back, mirroring the multi-week fade seen after both the Aug'25 and Apr'26 reports.",
  "day5_confidence": "LOW"
}